Literature DB >> 3145091

Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

S M Huson1, P S Harper, D A Compston.   

Abstract

A population-based study in south-east Wales (population 668,100) identified 135 patients with von Recklinghausen neurofibromatosis (prevalence 20/10(5]. In addition to multiple café-au-lait spots and/or dermal neurofibromas, freckling was present in the axilla (67%), groin (44%) or submammary areas (29% of adult females). Although not a criterion for diagnosis, Lisch nodules were almost invariably present in the iris (93% of patients overall; 96% of those aged greater than or equal to 20 yrs). The complications of von Recklinghausen neurofibromatosis in this cohort (n = 135 unless stated) were plexiform neurofibromas (40/125), severe mental retardation (1), epilepsy (6), optic glioma (2), spinal neurofibroma (2), aqueduct stenosis (2), meningioangiomatosis (1), scoliosis requiring surgery (6), pseudoarthrosis (3), delayed puberty (2), visceral and endocrine tumours (6), and congenital glaucoma (1). There were no cases of acoustic neuroma. Considering all living family members aged greater than or equal to 18 yrs, together with their deceased relatives, the frequency of CNS and malignant tumours related to the disease was 4.4-5.2%. Uncomplicated von Recklinghausen neurofibromatosis is disfiguring but not a major cause of morbidity. The management of the disease relates to its complications which can be divided into three categories: those which occur in childhood and cause lifelong morbidity (moderate-severe mental handicap, facial plexiform neurofibromas, orthopaedic), those which can occur at any time but are 'treatable' (benign disorders of the nervous system, visceral and endocrine tumours, renal artery stenosis), and malignant or CNS tumours. The combined frequency for each category based on this survey was 12%, 16% and 4.4-5.2%, respectively.

Entities:  

Mesh:

Year:  1988        PMID: 3145091     DOI: 10.1093/brain/111.6.1355

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  139 in total

1.  Abdominal neurofibromatosis.

Authors:  M R Thornton; F Campbell; C J Garvey; M J Hershman
Journal:  J R Soc Med       Date:  1999-11       Impact factor: 5.344

2.  Hereditary spinal neurofibromatosis: a rare form of NF1?

Authors:  M Poyhonen; E L Leisti; S Kytölä; J Leisti
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

3.  A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity.

Authors:  D G Evans; S M Huson; D Donnai; W Neary; V Blair; D Teare; V Newton; T Strachan; R Ramsden; R Harris
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

4.  Segregation analysis of peripheral neurofibromatosis (NF1).

Authors:  M Littler; N E Morton
Journal:  J Med Genet       Date:  1990-05       Impact factor: 6.318

5.  Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas.

Authors:  Michael J Ferguson; Steven D Rhodes; Li Jiang; Xiaohong Li; Jin Yuan; Xianlin Yang; Shaobo Zhang; Saeed T Vakili; Paul Territo; Gary Hutchins; Feng-Chun Yang; David A Ingram; D Wade Clapp; Shi Chen
Journal:  Pediatr Blood Cancer       Date:  2015-09-16       Impact factor: 3.167

6.  Unusual clustering of brain tumours in a family with NF1 and variable expression of cutaneous features.

Authors:  F Faravelli; M Upadhyaya; M Osborn; S M Huson; R Hayward; R Winter
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

7.  Management of massive lower limb plexiform neurofibromatosis--when to intervene?

Authors:  K T Power; J Giannas; Z Babar; D A McGrouther
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

8.  Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.

Authors:  Vincent Chau; S Kyun Lim; Wei Mo; Chiachi Liu; Amish J Patel; Renée M McKay; Shuguang Wei; Bruce A Posner; Jef K De Brabander; Noelle S Williams; Luis F Parada; Lu Q Le
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

9.  Bony orbital morphology in neurofibromatosis type 1 (NF1).

Authors:  S C Kaste; E K Pivnick
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

Review 10.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling.

Authors:  S M Huson; D A Compston; P S Harper
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.